Abstract
Despite being so common, bronchiolitis remains poorly diagnosed and managed. This article is intended as an update on issues pertaining to this condition.
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Antiviral Agents / therapeutic use
-
Bronchiolitis, Viral* / diagnosis
-
Bronchiolitis, Viral* / physiopathology
-
Bronchiolitis, Viral* / therapy
-
Bronchiolitis, Viral* / virology
-
Disease Management
-
Humans
-
Infant
-
Oxygen Inhalation Therapy / methods*
-
Palivizumab
-
Physical Examination / methods
-
Pre-Exposure Prophylaxis / methods*
-
Respiratory Syncytial Virus Infections* / diagnosis
-
Respiratory Syncytial Virus Infections* / physiopathology
-
Respiratory Syncytial Virus Infections* / therapy
-
Respiratory Syncytial Virus, Human / pathogenicity*
-
Risk Assessment
-
Seasons
-
South Africa
Substances
-
Antibodies, Monoclonal, Humanized
-
Antiviral Agents
-
Palivizumab